17 patents currently held
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Sep 2038. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Sep 2038
Next term end
7
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Sep 2038 · High confidence
Also notable
Ends Aug 2039 · High confidence
Also notable
Ends Jun 2041 · High confidence
Oligonucleotide Encoded Chemical Libraries
US 10,981,170
The most cited patent in this portfolio, cited by 16 later US patents, top 10% of utility patents granted in 2021 in our data. Protection runs to 2038.
Oligonucleotide Encoded Chemical Libraries
US 11,084,037
The most cited patent in this portfolio, cited by 16 later US patents, top 10% of utility patents granted in 2021 in our data. Protection runs to 2039.
Fluidic Device
US 11,642,675
The newest of the three, granted 2023. It anchors the portfolio to 2041, later than anything else here.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due May 7, 2027The maintenance fee for Quinazolinone Compounds and Related Compounds (US 11,807,620) comes due May 7, 2027. Unpaid by Nov 8, 2027, it lapses early.
- 1 fee due Jul 23, 2027The maintenance fee for Aryl Compounds and Pharmaceutical Compositions That Modulate IKZF2 (US 11,878,968) comes due Jul 23, 2027. Unpaid by Jan 24, 2028, it lapses early.
- 1 fee due Aug 27, 2027The maintenance fee for Caps for Assay Devices (US 11,911,760) comes due Aug 27, 2027. Unpaid by Feb 28, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
The 5 largest of its 7 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Oligonucleotide Encoded Chemical Libraries (2019) | 5 in force | to Mar 2041 |
| Oligonucleotide Encoded Chemical Libraries (2018) | 4 in force | to Aug 2039 |
| Fluidic Device | 2 in force | to Sep 2042 |
| Caps for Assay Devices | 2 in force | to May 2040 |
| Assay Devices for Combinatorial Libraries | 2 in force | to Jan 2040 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,828,643 | Oligonucleotide Encoded Chemical Libraries In force · Medium confidence | In force | Medium confidence | |
| US 10,946,383 | Oligonucleotide Encoded Chemical Libraries In force · High confidence | In force | High confidence | |
| US 10,981,170 | Oligonucleotide Encoded Chemical Libraries In force · High confidence | In force | High confidence | |
| US 12,030,057 | Oligonucleotide Encoded Chemical Libraries In force · Medium confidence | In force | Medium confidence | |
| US 11,577,249 | Oligonucleotide Encoded Chemical Libraries In force · High confidence | In force | High confidence | |
| US 12,629,683 | Oligonucleotide Encoded Chemical Libraries In force · Medium confidence | In force | Medium confidence | |
| US 11,084,037 | Oligonucleotide Encoded Chemical Libraries In force · High confidence | In force | High confidence | |
| US 11,027,272 | Transfer Dispensers for Assay Devices In force · High confidence | In force | High confidence | |
| US 11,040,343 | Caps for Assay Devices In force · High confidence | In force | High confidence | |
| US 11,305,288 | Assay Devices for Combinatorial Libraries In force · High confidence | In force | High confidence |
Also on record, not counted in the 17: 13 applications pending · 2 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.